Evidence map›Paper›PMID 40410690›Full record

ArticleBMC cancer2025

Evaluating the breast cancer quality of care indicators in Iran; multicenter study.

Mojtaba Vand Rajabpour, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Saeed Nemati, Shaghayegh Haghjooy Javanmard, Amirreza Manteghinejad, Sepideh Abdi, Borna Farazmand, Habibollah Pirnejad, Arash Golpazir Sorkheh and 17 more

Abstract readMulticenter Study
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Mojtaba Vand RajabpourCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Monireh Sadat SeyyedsalehiCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azin NahvijouCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Saeed NematiCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Shaghayegh Haghjooy JavanmardMetabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute ,Cellular and Molecular Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amirreza ManteghinejadCancer Prevention Research Center, Omid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Sepideh AbdiCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Borna FarazmandCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Habibollah PirnejadPatient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
Arash Golpazir SorkhehDepartment of Surgery, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Jamshid AnasariArak University of Medical Sciences, Arak, Iran.
Masoud BahramiClinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran.
Maryam MarzbanCellular and Molecular Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Seyedeh Masoumeh GhoreishiCellular and Molecular Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Yahya Baharvand Iran NiaDepartment of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Fataneh BakhshiSocial Determinants of Health Research Center, School of Health, Gilan University of Medical Sciences, Rasht, Iran.
Alireza Ansari-MoghaddamHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Maryam Moradi BinabajNon-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Hassan NourmohammadiDepartment of Internal Medicine Shahid, Mostafa Khomeini Hospital, Ilam, Iran.
Ramesh OmranipourBreast Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Alireza AbdollahiDepartment of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahdi AghiliRadiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali MohagheghiCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ali Ghanbari-MotlaghDepartment of Radiotherapy, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Partha BasuInternational Agency for Research On Cancer, Lyone, France.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
Kazem ZendehdelCancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. kzendeh@sina.tums.ac.ir.

Funding

Tehran University of Medical Sciences and Health Services 42172-51-02-98World Health Organization 001
6 · The paper itself

Abstract

backgroundData on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.

methodA total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.

resultIn the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.

conclusionThe defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.

Indexed as

Breast NeoplasmsQuality Indicators, Health CareQuality of Health CareAdultAgedFemaleHumansIranMiddle AgedRegistriesRetrospective StudiesBreast NeoplasmCountriesDevelopingEUSOMAHealthcareIndicatorsQuality of CareSystem

Identifiers

PMID40410690
PMCPMC12100878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.